Skip to Main Content

Paper Details

Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.
Oncotarget
37
2017
AR, CNA, CNAs, PRINCe, advanced cancer, advanced cancers, cancer, cell-free DNA, cfDNA, cfDNA samples, mCRPC, men, metastatic castration-resistant prostate cancer, patient, patients, tumor
Author NameAffiliation
Daniel H HovelsonMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Daniel H HovelsonUniversity of Michigan Medical School ann arbor
Moshe TalpazUniversity of Michigan Medical School ann arbor
Felix Y FengUniversity of California at San Francisco
Robert J LonigroMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Robert J LonigroUniversity of Michigan Medical School ann arbor
Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Dan R RobinsonDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Dan R RobinsonUniversity of Michigan Medical School ann arbor
David C SmithUniversity of Michigan Medical School ann arbor
David C SmithDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Maha HussainUniversity of Michigan Medical School ann arbor
Maha HussainFeinberg School of Medicine, Northwestern University
Maha HussainDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of California, Los Angeles and the Jonsson Comprehensive Cancer Center
Arul M ChinnaiyanDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of California, Los Angeles and the Jonsson Comprehensive Cancer Center
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariDepartment of Biointerfaces Institute, University of Michigan Medical School ann arbor
Muneesh TewariDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariUniversity of Michigan Medical School ann arbor
Muneesh TewariDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Muneesh TewariDepartment of Biointerfaces Institute, University of Michigan Medical School ann arbor
Ryan E MillsUniversity of Michigan Medical School ann arbor
Ryan E MillsUniversity of Michigan Medical School ann arbor
Todd M MorganMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Todd M MorganUniversity of Michigan Medical School ann arbor
Todd M MorganDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
Scott A TomlinsMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Scott A TomlinsUniversity of Michigan Medical School ann arbor
Scott A TomlinsUniversity of Michigan Medical School ann arbor
Scott A TomlinsDepartment of Comprehensive Cancer Center, University of Michigan Medical School ann arbor
  • 1 - 43

Datasets